Search research articles
Contact Us
Filters
Showing results (181-190 of 234) with videos related to
Page
of 24
Sort By:
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
October 15, 2024
Trastuzumab Deruxtecan with Nivolumab in HER2-Expressing Metastatic Breast or Urothelial Cancer: Analysis of the Phase Ib DS8201-A-U105 Study
Erika Hamilton, Matthew D Galsky, Sebastian Ochsenreither, et al.
Urologic Oncology
|
February 8, 2021
Patterns and timing of perioperative blood transfusion and association with outcomes after radical cystectomy
Leonidas N Diamantopoulos, Rishi R Sekar, Sarah K Holt, et al.
Clinical Genitourinary Cancer
|
May 7, 2023
Sarcomatoid Urothelial Carcinoma Is Associated With Limited Response to Neoadjuvant Chemotherapy and Poor Oncologic Outcomes After Radical Cystectomy
Rishi R Sekar, Leonidas N Diamantopoulos, Dimitra R Bakaloudi, et al.
Urologic Oncology
|
May 2, 2025
Prospective evaluation of comprehensive geriatric assessments in multidisciplinary bladder cancer care and implications for personalized vulnerability phenotyping
Dana Cavanaugh, Sarah K Holt, Erin Dwyer, et al.
European Urology
|
August 5, 2025
Neoadjuvant Pembrolizumab and Accelerated Methotrexate, Vinblastine, Doxorubicin, and Cisplatin in Nonurothelial Histologic Subtypes of Muscle-invasive Bladder Cancer: A Phase 2 Trial
Ruben Raychaudhuri, Ali Raza Khaki, Mary W Redman, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
October 30, 2024
Association of Tumor Mutational Burden and PD-L1 with the Efficacy of Pembrolizumab with or without Chemotherapy versus Chemotherapy in Advanced Urothelial Carcinoma
Aude Fléchon, Rafael Morales-Barrera, Thomas Powles, et al.
BJU International
|
November 5, 2020
Neoadjuvant chemotherapy plus radical cystectomy versus radical cystectomy alone in clinical T2 bladder cancer without hydronephrosis
Francesco Soria, Peter C Black, Adrian S Fairey, et al.
Urologic Oncology
|
September 3, 2025
Agreement between transurethral resection of bladder tumor and radical cystectomy pathology in patients with bladder cancer subtype histology: A retrospective cohort study
Dimitra Rafailia Bakaloudi, Elizabeth L Koehne, Jenna M Voutsinas, et al.
Research Square
|
January 10, 2024
ASSESSMENT OF CELL SURFACE TARGETS IN METASTATIC PROSTATE CANCER: EXPRESSION LANDSCAPE AND MOLECULAR CORRELATES
Azra Ajkunic, Erolcan Sayar, Martine P Roudier, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
September 26, 2023
Tucatinib and Trastuzumab for Previously Treated Human Epidermal Growth Factor Receptor 2-Positive Metastatic Biliary Tract Cancer (SGNTUC-019): A Phase II Basket Study
Yoshiaki Nakamura, Nobumasa Mizuno, Yu Sunakawa, et al.
Page
of 24
Search research articles
Search
Showing results (181-190 of 234) with videos related to
Sort By:
Page
of 24
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
October 15, 2024
Trastuzumab Deruxtecan with Nivolumab in HER2-Expressing Metastatic Breast or Urothelial Cancer: Analysis of the Phase Ib DS8201-A-U105 Study
Erika Hamilton, Matthew D Galsky, Sebastian Ochsenreither, et al.
Urologic Oncology
|
February 8, 2021
Patterns and timing of perioperative blood transfusion and association with outcomes after radical cystectomy
Leonidas N Diamantopoulos, Rishi R Sekar, Sarah K Holt, et al.
Clinical Genitourinary Cancer
|
May 7, 2023
Sarcomatoid Urothelial Carcinoma Is Associated With Limited Response to Neoadjuvant Chemotherapy and Poor Oncologic Outcomes After Radical Cystectomy
Rishi R Sekar, Leonidas N Diamantopoulos, Dimitra R Bakaloudi, et al.
Urologic Oncology
|
May 2, 2025
Prospective evaluation of comprehensive geriatric assessments in multidisciplinary bladder cancer care and implications for personalized vulnerability phenotyping
Dana Cavanaugh, Sarah K Holt, Erin Dwyer, et al.
European Urology
|
August 5, 2025
Neoadjuvant Pembrolizumab and Accelerated Methotrexate, Vinblastine, Doxorubicin, and Cisplatin in Nonurothelial Histologic Subtypes of Muscle-invasive Bladder Cancer: A Phase 2 Trial
Ruben Raychaudhuri, Ali Raza Khaki, Mary W Redman, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
October 30, 2024
Association of Tumor Mutational Burden and PD-L1 with the Efficacy of Pembrolizumab with or without Chemotherapy versus Chemotherapy in Advanced Urothelial Carcinoma
Aude Fléchon, Rafael Morales-Barrera, Thomas Powles, et al.
BJU International
|
November 5, 2020
Neoadjuvant chemotherapy plus radical cystectomy versus radical cystectomy alone in clinical T2 bladder cancer without hydronephrosis
Francesco Soria, Peter C Black, Adrian S Fairey, et al.
Urologic Oncology
|
September 3, 2025
Agreement between transurethral resection of bladder tumor and radical cystectomy pathology in patients with bladder cancer subtype histology: A retrospective cohort study
Dimitra Rafailia Bakaloudi, Elizabeth L Koehne, Jenna M Voutsinas, et al.
Research Square
|
January 10, 2024
ASSESSMENT OF CELL SURFACE TARGETS IN METASTATIC PROSTATE CANCER: EXPRESSION LANDSCAPE AND MOLECULAR CORRELATES
Azra Ajkunic, Erolcan Sayar, Martine P Roudier, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
September 26, 2023
Tucatinib and Trastuzumab for Previously Treated Human Epidermal Growth Factor Receptor 2-Positive Metastatic Biliary Tract Cancer (SGNTUC-019): A Phase II Basket Study
Yoshiaki Nakamura, Nobumasa Mizuno, Yu Sunakawa, et al.
Page
of 24